March 21, 2012 -- China Shijiazhuang Pharma (CSPC), a company that has traditionally been known as a maker of bulk pharmaceuticals, is expanding into patented, innovative drugs. The company said it would focus on five disease sectors: cardiovascular, cerebrovascular, neurology, endocrinology (diabetes) as well as metabolism/digestion. More details....
Stock Symbol: (HK: 1093)
